Author + information
- Received April 30, 1992
- Revision received July 10, 1992
- Accepted July 21, 1992
- Published online February 1, 1993.
- James D. Rossen, MD, FACC∗ and
- Michael D. Winniford, MD, FACC
- ↵∗Addresser correspondence: James D. Rossen. MD. Department of Internal Medicine, 4216 RCP, The University of Iowa, Iowa City, Iowa 52242.
Objectives. The objective of this study was to determine the effect of increases in heart rate and arterial pressure on maximal pharmacologic coronary Wood flow reserve.
Background. Coronary flow reserve measurements are useful in assessment of the physiologic significance of coronary lesions. However, animal studies suggest that alterations in hemodynamic status may influence coronary flow reserve independent of coronary stenosis.
Methods. Coronary flow reserve was measured during cardiac catheterization with the use of a 3F coronary Doppler catheter and intracoronary papaverine. Flow reserve was measured under control conditions and during increases in heart rate produced by atrial pacing (18 patients) or during elevation of arterial pressure by intravenous phenylephrine infusion (9 patients) with intracoronary alpha-adrenergic blockade by phentolamine.
Results. Coronary flow reserve progressively decreased from 3.7 ± 0.9 (mean ± SD) at the rate of 71 ± 8 beats/min at rest to 3.0 ± 0.6 during pacing at 100 beats/min and to 2.6 ± 0.5 during pacing at 120 beats/min. Flow reserve decreased because of a progressive increase in rest coronary flow velocity during pacing (122 +- 16% of control value at 100 beats/min, 139 ± 16% of control value at 120 beats/min), whereas papaverine hyperemia peak velocity remained unchanged. Flow reserve decreased with pacing tachycardia whether the initial flow reserve was normal or depressed. Mean arterial pressure increased from 95 ± 12 mm Hg to 130 ± 8 mm Hg daring intravenous phenylephrine infusion and to 123 ± 10 mm Hg during combined intravenous phenylephrine and intracoronary phentolamine infusions. Coronary flow reserve was not affected by the blood pressure increases control value 4.3 ± 1.0, phenytephrine 4.4 ± 1.5, phenylephrine and phentolamine 4.4 ± 2.0).
Conclusions. Sudden increases in heart rate but not mean arterial pressure lead to a substantial reduction in maximal coronary blood flow reserve. These data suggest that the diagnostic utility of all flow reserve measurement techniques might be improved by standardization of heart rate during measurement or extrapolation of the measured flow reserve to that expected at a reference heart rate.
☆ This study was supported in part by the Ischemic Specialized Center of Research Grant HL 32295 from the National Heart, Lung, and Blood Institutes, National Institutes of Health, Bethesda, Maryland.
- Received April 30, 1992.
- Revision received July 10, 1992.
- Accepted July 21, 1992.